Viewing Study NCT06181006


Ignite Creation Date: 2025-12-26 @ 5:19 PM
Ignite Modification Date: 2026-04-08 @ 3:21 PM
Study NCT ID: NCT06181006
Status: COMPLETED
Last Update Posted: 2025-01-14
First Post: 2023-12-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate Pirtobrutinib (LOXO-305) in Healthy Adult Participants
Sponsor: Eli Lilly and Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: LOXO-BTK-20017
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View